openPR Logo
Press release

Investigation announced for Long-Term Investors in shares of Moderna, Inc. (NASDAQ: MRNA) over potential Wrongdoing

An investigation on behalf of current long term investors in Moderna, Inc. (NASDAQ: MRNA) shares.

An investigation on behalf of current long term investors in Moderna, Inc. (NASDAQ: MRNA) shares.

An investigation was announced for current long-term investors in shares of Moderna, Inc. (NASDAQ: MRNA) concerning potential breaches of fiduciary duties by certain directors of Moderna, Inc.

Investors who are current long term investors in Moderna, Inc. (NASDAQ: MRNA) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: MRNA stocks follows a lawsuit filed against Moderna, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: MRNA stocks, concerns whether certain Moderna, Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of Massachusetts the plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that mRNA-1345 was less effective than Defendants had led investors to believe, that accordingly, mRNA-1345's clinical and/or commercial prospects were overstated, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of Moderna, Inc. (NASDAQ: MRNA) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Long-Term Investors in shares of Moderna, Inc. (NASDAQ: MRNA) over potential Wrongdoing here

News-ID: 3910620 • Views:

More Releases from Shareholders Foundation, Inc.

Investigation announced for Long-Term investors in shares of Target Corporation (NYSE: TGT) over potential Wrongdoing
Investigation announced for Long-Term investors in shares of Target Corporation …
An investigation was announced for current long-term investors in shares of Target Corporation (NYSE: TGT) concerning potential breaches of fiduciary duties by certain directors of Target Corporation. Investors who are current long term investors in Target Corporation (NYSE: TGT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NYSE: TGT
Ready Capital Corporation (NYSE: RC) Shareholder NOTICE: Deadline in Lawsuit on May 05, 2025
Ready Capital Corporation (NYSE: RC) Shareholder NOTICE: Deadline in Lawsuit on …
A deadline is coming up on May 05, 2025 in the lawsuit filed for certain investors of Ready Capital Corporation (NYSE: RC) over alleged securities laws violations by Ready Capital Corporation. Investors who purchased shares of Ready Capital Corporation (NYSE: RC) have certain options and there are strict and short deadlines running. Deadline: May 05, 2025. Ready Capital Corporation (NYSE: RC) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call
Long-Term Investors who hold shares of Applied Therapeutics, Inc. (NASDAQ: APLT) should contact the Shareholders Foundation in connection with Investigation over potential Wrongdoing
Long-Term Investors who hold shares of Applied Therapeutics, Inc. (NASDAQ: APLT) …
An investigation was announced on behalf of current long-term investors in shares of Applied Therapeutics, Inc. (NASDAQ: APLT) concerning potential breaches of fiduciary duties by certain directors and officers of Applied Therapeutics, Inc. Investors who are current long term investors in Applied Therapeutics, Inc. (NASDAQ: APLT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for
Lawsuit filed for Investors who lost money with shares of NET Power Inc. (NYSE: NPWR)
Lawsuit filed for Investors who lost money with shares of NET Power Inc. (NYSE: …
An investor, who purchased shares of NET Power Inc. (NYSE: NPWR), filed a lawsuit in the U.S. District Court for the Middle District of North Carolina over alleged violations of Federal Securities Laws by NET Power Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of NET Power Inc. (NYSE: NPWR) have certain options and for certain investors are short and strict deadlines running. Deadline: June

All 5 Releases


More Releases for Moderna

mRNA Therapy Market Projected to Show Strong Growth | Astrazeneca, Moderna, BioN …
The Latest survey report on mRNA Therapy Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, mRNA Therapy organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc., Astrazeneca & CureVac. Staying ahead in business
Vaccine Contract Manufacturing Market is Growing Rapidly with Catalent, Moderna
Contract manufacturing is a complex process involved in producing vaccine products. This type of production usually involves the manufacturing of vaccines in a single step. Contract manufacturers usually produce vaccines at their facilities; however, some contract manufacturers also service the field through the provision of workspace and by taking care of the closing storage and final disposition of finished products. Some contract manufacturers specialize in the manufacture of one or
Coronavirus Market to See Major Growth by 2026 | Moderna,Novavax
The Latest Released Coronavirus market study has evaluated the future growth potential of Global Coronavirus market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, emerging trends along with essential drivers, challenges, opportunities
Investigation announced for Long-Term Investors in Moderna, Inc. (NASDAQ: MRNA) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Moderna, Inc. Investors who purchased shares of Moderna, Inc. (NASDAQ: MRNA) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Moderna directors breached their fiduciary duties and caused damage to the company and its shareholders. Cambridge, MA based Moderna, Inc.,
Coronavirus Vaccine Investment Market Still Going Strong | AbbVie, Novavax, Pfiz …
The coronavirus (COVID-19) disease is affecting 210 countries and territories around the world and 2 international conveyances. The major players are investing in the research and development activities of the coronavirus vaccine. In the race to develop a vaccine to end the COVID-19 pandemic, governments, charities and Big Pharma firms are sinking billions of dollars into bets with extraordinarily low odds of success. They are ensuring quick development of new
Coronavirus Medicine Market Evolving Opportunities With | Gilead Sciences, Moder …
Research Reports Inc has released the newest report supported thorough research on Coronavirus Medicine Market. This report discusses this industry's market in types of Size/definition, application, classification, predictions concerning value and volume, and future predictions. It also prominently attributes the present situation and outlooks with the economic and financial aspects. This section also examines factors influencing the growth of the market along with detailing the top trends, drivers, restraints, regional